Methylprednisolone hemisuccinate
- Generic Name
- Methylprednisolone hemisuccinate
- Brand Names
- Solu-medrol
- Drug Type
- Small Molecule
- Chemical Formula
- C26H34O8
- CAS Number
- 2921-57-5
- Unique Ingredient Identifier
- 5GMR90S4KN
- Background
A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.
- Associated Conditions
- Acute Gouty Arthritis, Ankylosing Spondylitis (AS), Berylliosis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Dermatitis bullous, Dermatomyositis (DM), Edema of the cerebrum, Hypercalcemia of Malignancy, Immune Thrombocytopenia (ITP), Leukemias, Lymphoma, Multiple sclerosis exacerbation, Mycosis Fungoides (MF), Ophthalmia, Sympathetic, Pemphigus, Polymyositis, Primary adrenocortical insufficiency, Psoriatic Arthritis, Pure Red Cell Aplasia, Refractory Uveitis, Regional Enteritis, Rheumatoid Arthritis, Secondary adrenocortical insufficiency, Secondary thrombocytopenia, Stevens-Johnson Syndrome, Systemic Lupus Erythematosus, Temporal Arteritis, Trichinosis, Tuberculous Meningitis, Ulcerative Colitis, Acquired immune hemolytic anemia, Acute rheumatic carditis, Disseminated Pulmonary Tuberculosis (TB), Exfoliative erythroderma, Fulminating Pulmonary Tuberculosis, Idiopathic eosinophilic pneumonias, Non-suppurative Thyroiditis, Severe Allergic Reactions, Symptomatic Sarcoidosis
- Associated Therapies
- Palliative Treatment
EEG Changes in Pediatrics With Language Dysfunction Evaluation of Sleep EEG Changes in Paediatric Patients With Language Dysfunction: A Follow up Study. EEG Changes in Pediatrics With Language Dysfunction
Phase 3
Completed
- Conditions
- Language Disorders in Children
- Interventions
- First Posted Date
- 2022-08-04
- Last Posted Date
- 2022-08-04
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 93
- Registration Number
- NCT05487521
- Locations
- 🇪🇬
Omnia Alaa Mahsoub, Cairo, Egypt
Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
Phase 2
Active, not recruiting
- Conditions
- ST Elevation Myocardial InfarctionInflammatory ResponseMyocardial Reperfusion InjuryMyocardial Injury
- Interventions
- Drug: Isotonic saline
- First Posted Date
- 2022-07-18
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Thomas Engstrom
- Target Recruit Count
- 530
- Registration Number
- NCT05462730
- Locations
- 🇩🇰
Heart Center, Rigshospitalet, Copenhagen, Capital Region, Denmark
Pain Increases After Shoulder Injection
Phase 4
Completed
- Conditions
- Shoulder Pain
- Interventions
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2023-03-07
- Lead Sponsor
- Campbell Clinic
- Target Recruit Count
- 421
- Registration Number
- NCT05438277
- Locations
- 🇺🇸
Campbell Clinic, Germantown, Tennessee, United States
Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients
Phase 3
Completed
- Conditions
- COVID-19 Respiratory InfectionFLUCold; InfluenzaBacterial PneumoniaCOVID-19 Pneumonia
- Interventions
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2022-06-14
- Lead Sponsor
- RAAS Nutritionals, LLC
- Target Recruit Count
- 71
- Registration Number
- NCT05417997
- Locations
- 🇹🇷
Kayseri City Hospital, Kayseri, Kayseri Province, Turkey
Multi-Modal Anesthesia Protocol in Pain Management of Patients Undergoing Posterior Lumbar Spinal Fusion Surgery
Phase 4
Completed
- Conditions
- Pain ManagementPosterior Spinal Fusion
- Interventions
- First Posted Date
- 2022-06-10
- Last Posted Date
- 2022-06-10
- Lead Sponsor
- University of Puerto Rico
- Target Recruit Count
- 100
- Registration Number
- NCT05413902
- Locations
- 🇵🇷
Puerto Rico Medical Center - University District Hospital, San Juan, Puerto Rico
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
Phase 3
Active, not recruiting
- Conditions
- Plasma Cell Myeloma Recurrent
- Interventions
- First Posted Date
- 2022-06-06
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 531
- Registration Number
- NCT05405166
- Locations
- 🇺🇸
Arizona Oncology Associates, PC - HAL- Site Number : 8400015, Prescott Valley, Arizona, United States
🇺🇸Rocky Mountain Cancer Centers, LLP- Site Number : 8400021, Aurora, Colorado, United States
🇺🇸Mayo Clinic- Site Number : 8400008, Jacksonville, Florida, United States
MAP-guided Preemptive Therapy of aGvHD
Phase 2
Recruiting
- Conditions
- GVHD,AcuteStem Cell Transplant Complications
- Interventions
- First Posted Date
- 2022-05-10
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Sichuan University
- Target Recruit Count
- 56
- Registration Number
- NCT05368181
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Sichuan, China
An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy
Completed
- Conditions
- Purtscher RetinopathyPancreatic Cancer
- First Posted Date
- 2022-04-28
- Last Posted Date
- 2022-04-28
- Lead Sponsor
- University of Catania
- Target Recruit Count
- 1
- Registration Number
- NCT05350384
- Locations
- 🇮🇹
Eva Intagliata, Catania, Italy
PreOperative Methylprednisolone on Thoracic Endovascular Repair for Reducing Post-implantation Syndrome (POMTEVAR)
Not Applicable
Not yet recruiting
- Conditions
- MethylprednisoloneThoracic Endovascular RepairPost-implantation SyndromeType B Aortic Dissection
- Interventions
- Drug: physiological saline
- First Posted Date
- 2022-04-27
- Last Posted Date
- 2022-04-27
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 158
- Registration Number
- NCT05349071
Sirolimus in Graves' Orbitopathy
- First Posted Date
- 2022-04-25
- Last Posted Date
- 2022-04-25
- Lead Sponsor
- University of Pisa
- Target Recruit Count
- 30
- Registration Number
- NCT05345119
- Locations
- 🇮🇹
Endocrinologia II, Pisa, PI, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath